Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03435770
Recruitment Status : Unknown
Verified February 2018 by Chin Yung Ka, Singapore General Hospital.
Recruitment status was:  Not yet recruiting
First Posted : February 19, 2018
Last Update Posted : February 20, 2018
Information provided by (Responsible Party):
Chin Yung Ka, Singapore General Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 1, 2019
Estimated Study Completion Date : September 1, 2019
1. Pai M, Yang J, Zhang X, Jin Z, Wang D, Senturk H, Lakhtakia S, Reddy DN, Kahaleh M, Habib N, et al. Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) for pancreatic ductal adenocarcinoma. Gut. 2013;62(Suppl 1):A153.
Pai M, Senturk H, Lakhtakia S, Reddy DN, Cicinnati C, Kabar I, Beckebaum S, Jin Z, Wang D, Yang J, et al. Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Cystic Neoplasms and Neuroendocrine Tumours of the Pancreas. Gastrointest Endosc. 2013;77(5S): AB143-AB144